000623 吉林敖东
已收盘 04-30 15:00:00
资讯
新帖
简况
吉林敖东(000623)2025年一季报简析:净利润增259.75%,三费占比上升明显
证券之星 · 04-30
吉林敖东(000623)2025年一季报简析:净利润增259.75%,三费占比上升明显
吉林敖东:公司本次回购股票的目的系为维护公司价值及股东权益
证券之星 · 04-30
吉林敖东:公司本次回购股票的目的系为维护公司价值及股东权益
吉林敖东:关于2025年第一季度每股净资产的计算说明
证券之星 · 04-30
吉林敖东:关于2025年第一季度每股净资产的计算说明
图解吉林敖东一季报:第一季度单季净利润同比增259.75%
证券之星 · 04-29
图解吉林敖东一季报:第一季度单季净利润同比增259.75%
吉林敖东(000623.SZ)发布一季度业绩,归母净利润5.17亿元,同比增长259.75%
智通财经 · 04-29
吉林敖东(000623.SZ)发布一季度业绩,归母净利润5.17亿元,同比增长259.75%
吉林敖东(000623)3月31日股东户数6.7万户,较上期减少0.6%
证券之星 · 04-29
吉林敖东(000623)3月31日股东户数6.7万户,较上期减少0.6%
吉林敖东股价微涨0.25% 融资余额降至12.17亿元
金融界 · 04-25
吉林敖东股价微涨0.25% 融资余额降至12.17亿元
吉林敖东(000623.SZ)发布2024年度业绩,归母净利润15.51亿元,同比增长6.27%
智通财经 · 04-22
吉林敖东(000623.SZ)发布2024年度业绩,归母净利润15.51亿元,同比增长6.27%
吉林敖东:公司核心业务与吉林省“医药强省”战略方向一致
证券之星 · 03-10
吉林敖东:公司核心业务与吉林省“医药强省”战略方向一致
吉林敖东:中医药政策持续利好,公司将探索高质量发展路径
证券之星 · 03-10
吉林敖东:中医药政策持续利好,公司将探索高质量发展路径
吉林敖东:公司核心业务涵盖中药、化药、生物制药及参业资源开发
互动易 · 03-10
吉林敖东:公司核心业务涵盖中药、化药、生物制药及参业资源开发
吉林敖东:公司持有的广发证券采用权益法作为长期股权投资核算
证星董秘互动 · 02-22
吉林敖东:公司持有的广发证券采用权益法作为长期股权投资核算
吉林敖东:公司持有广发证券采用权益法核算,第一医药、南京医药为交易性金融资产核算
金融界 · 02-22
吉林敖东:公司持有广发证券采用权益法核算,第一医药、南京医药为交易性金融资产核算
吉林敖东:公司高度重视员工激励机制的建设
证券之星 · 02-21
吉林敖东:公司高度重视员工激励机制的建设
吉林敖东:公司在生产经营中积极与国内多家信息科技公司合作
证券之星 · 02-13
吉林敖东:公司在生产经营中积极与国内多家信息科技公司合作
吉林敖东:公司目前经营的主业范围不涉及AI+相关业务
证券之星 · 02-11
吉林敖东:公司目前经营的主业范围不涉及AI+相关业务
吉林敖东最新公告:控股子公司延边药业通过药品GMP符合性检查
证券之星 · 02-10
吉林敖东最新公告:控股子公司延边药业通过药品GMP符合性检查
加载更多
公司概况
公司名称:
吉林敖东药业集团股份有限公司
所属行业:
医药制造业
上市日期:
1996-10-28
主营业务:
吉林敖东药业集团股份有限公司的主营业务是中药、化学药品研发、制造和销售。公司的主要产品是中药、化学药品、连锁药店批发、零售。作为中华老字号及国家火炬计划重点高新技术企业,公司资产规模稳健增长,截至2024年末总资产达330.02亿元,净资产292.82亿元。凭借卓越的综合实力和行业影响力,公司连续十余年荣登中国制药工业百强榜单,2024中国中药研发实力排行榜TOP50中药榜第26位,并跻身“中国500最具价值品牌”,资产质量稳居行业前列。
发行价格:
7.20
{"stockData":{"symbol":"000623","market":"SZ","secType":"STK","nameCN":"吉林敖东","latestPrice":15.97,"timestamp":1745996598000,"preClose":15.66,"halted":0,"volume":16444183,"delay":0,"changeRate":0.0198,"floatShares":1191000000,"shares":1196000000,"eps":1.6094,"marketStatus":"已收盘","change":0.31,"latestTime":"04-30 15:00:00","open":15.96,"high":16.44,"low":15.96,"amount":265000000,"amplitude":0.0307,"askPrice":15.97,"askSize":671,"bidPrice":15.96,"bidSize":522,"shortable":0,"etf":0,"ttmEps":1.6094,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":5,"adr":0,"adjPreClose":15.66,"symbolType":"stock","openAndCloseTimeList":[[1745976600000,1745983800000],[1745989200000,1745996400000]],"highLimit":17.23,"lowLimit":14.09,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1195895387,"isCdr":false,"pbRate":0.65,"roa":"--","peRate":9.922953,"roe":"1.77%","epsLYR":1.3179,"committee":-0.434462,"marketValue":19098000000,"turnoverRate":0.0138,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-05-06。","floatMarketCap":19022000000},"requestUrl":"/m/hq/s/000623","defaultTab":"news","newsList":[{"id":"2532018227","title":"吉林敖东(000623)2025年一季报简析:净利润增259.75%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2532018227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532018227?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:46","pubTimestamp":1746053217,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期吉林敖东发布2025年一季报。截至本报告期末,公司营业总收入6.23亿元,同比下降27.71%,归母净利润5.17亿元,同比上升259.75%。本报告期吉林敖东三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达35.31%。然而去年的净利率为58.19%,算上全部成本后,公司产品或服务的附加值极高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100005103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623"],"gpt_icon":0},{"id":"2531324480","title":"吉林敖东:公司本次回购股票的目的系为维护公司价值及股东权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2531324480","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531324480?lang=zh_cn&edition=full","pubTime":"2025-04-30 20:52","pubTimestamp":1746017550,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东04月29日在投资者关系平台上答复投资者关心的问题。公司本次回购股票的目的系为维护公司价值及股东权益。本次回购股份将在回购股份实施结果暨股份变动公告12个月后采用集中竞价交易方式出售,并在回购股份实施结果暨股份变动公告后36个月内予以出售。若公司未能在上述期限内出售完毕,未出售股份将被注销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000045237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0188","BK0028","BK0074","000623","BK0086","BK0239","BK0012"],"gpt_icon":0},{"id":"2531470435","title":"吉林敖东:关于2025年第一季度每股净资产的计算说明","url":"https://stock-news.laohu8.com/highlight/detail?id=2531470435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531470435?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:27","pubTimestamp":1746001635,"startTime":"0","endTime":"0","summary":"投资者提问:2024年报每股净资产24.27。2025年第一季度每股收益0.44元,所以2025年第一季度每股净资产应该是24.71元。关于2025年第一季度每股净资产的计算,您可能存在数据解读上的误区,当期每股净资产并非是2024年末每股净资产与2025年第一季度每股收益的简单加总获得,还涉及其他财务指标,我们建议您查阅公司发布的2025年第一季度财务报告,其中详细列出了所有影响每股净资产的财务活动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000032797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0239","BK0086","000623","BK0188","BK0074","BK0201"],"gpt_icon":0},{"id":"2531785106","title":"图解吉林敖东一季报:第一季度单季净利润同比增259.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531785106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531785106?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:55","pubTimestamp":1745924136,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东2025年一季报显示,公司主营收入6.23亿元,同比下降27.71%;归母净利润5.17亿元,同比上升259.75%;扣非净利润4.88亿元,同比上升75.56%;负债率11.43%,投资收益5.08亿元,财务费用266.77万元,毛利率47.11%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900036831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623"],"gpt_icon":0},{"id":"2531834107","title":"吉林敖东(000623.SZ)发布一季度业绩,归母净利润5.17亿元,同比增长259.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531834107","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531834107?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:49","pubTimestamp":1745923743,"startTime":"0","endTime":"0","summary":"智通财经APP讯,吉林敖东(000623.SZ)发布2025年一季度报告,第一季度,公司实现营业收入6.23亿元,同比下降27.71%。归属于上市公司股东的净利润5.17亿元,同比增长259.75%。归属于上市公司股东的扣除非经常性损益的净利润4.88亿元,同比增长75.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000623"],"gpt_icon":0},{"id":"2531943209","title":"吉林敖东(000623)3月31日股东户数6.7万户,较上期减少0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531943209","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531943209?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:38","pubTimestamp":1745919502,"startTime":"0","endTime":"0","summary":"证券之星消息,近日吉林敖东披露,截至2025年3月31日公司股东户数为6.7万户,较12月31日减少405.0户,减幅为0.6%。在中药行业个股中,吉林敖东股东户数高于行业平均水平,截至3月31日,中药行业平均股东户数为5.23万户。从股价来看,2024年12月31日至2025年3月31日,吉林敖东区间跌幅为4.69%,在此期间股东户数减少405.0户,减幅为0.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900033743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0188","BK0239","000623","BK0201","BK0012","BK0074","BK0028"],"gpt_icon":0},{"id":"2530348701","title":"吉林敖东股价微涨0.25% 融资余额降至12.17亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530348701","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530348701?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:55","pubTimestamp":1745589340,"startTime":"0","endTime":"0","summary":"截至2025年4月25日15时,吉林敖东股价报15.75元,较前一交易日上涨0.04元,涨幅0.25%。当日开盘价为15.73元,最高触及15.85元,最低15.73元,成交额1.29亿元,换手率0.69%。吉林敖东主营业务涵盖化学制药及参股券商等领域,是吉林省重点医药企业之一。公司总市值188.35亿元,市盈率12.14,市净率0.65。4月24日数据显示,吉林敖东融资净偿还1397.08万元,融资余额降至12.17亿元,较前一日减少1.13%。当日融资买入1282.26万元,融资偿还2679.34万元。风险提示:市场有风险,投资需谨慎。\n\n\r\n 责任编辑:磐石","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/25215549898460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000623","BK0028","BK0074","BK0188","BK0201","BK0012","BK0086","BK0239"],"gpt_icon":0},{"id":"2529301813","title":"吉林敖东(000623.SZ)发布2024年度业绩,归母净利润15.51亿元,同比增长6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529301813","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529301813?lang=zh_cn&edition=full","pubTime":"2025-04-22 20:24","pubTimestamp":1745324656,"startTime":"0","endTime":"0","summary":"智通财经APP讯,吉林敖东(000623.SZ)发布2024年年度报告,报告期内,公司实现营业收入26.11亿元,同比下降24.31%。实现归属于上市公司股东的净利润15.51亿元,同比增长6.27%。实现归属于上市公司股东的扣除非经常性损益的净利润15.73亿元,同比增长19.76%。基本每股收益为1.3179元。拟向全体股东每10股派发现金红利3.00元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000623"],"gpt_icon":0},{"id":"2518322934","title":"吉林敖东:公司核心业务与吉林省“医药强省”战略方向一致","url":"https://stock-news.laohu8.com/highlight/detail?id=2518322934","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518322934?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:51","pubTimestamp":1741611072,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东03月09日在投资者关系平台上答复投资者关心的问题。证监会发布“积极支持符合条件的吉林省企业通过首发和再融资募集资金,利用资本市场做大做强,充分发挥资本市场对吉林省经济发展的支持作用。”公司核心业务涵盖中药、化药、生物制药及参业资源开发,与吉林省“医药强省”战略方向一致。具体情况请以公司在指定媒体披露的信息为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031000031705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0012","BK0201","BK1515","BK0074","BK1161","159938","09939","000623","BK0086","BK0188","BK0239","BK0028"],"gpt_icon":0},{"id":"2518344229","title":"吉林敖东:中医药政策持续利好,公司将探索高质量发展路径","url":"https://stock-news.laohu8.com/highlight/detail?id=2518344229","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518344229?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:51","pubTimestamp":1741611070,"startTime":"0","endTime":"0","summary":"证监会发布“将继续推动并购重组市场化改革,认真落实国家产业政策,多措并举活跃并购重组市场,持续助力中医药上市公司通过并购重组实现高质量发展。”中医药作为国家重点发展领域,政策端持续释放利好,推动行业资源整合,助力企业提升核心竞争力。在政策支持医药企业高质量发展大背景下,公司将依托自身优势,探索符合国家产业政策的高质量发展路径。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031000031702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0201","BK0239","000623","BK0012","BK0086","BK0074","BK0028"],"gpt_icon":0},{"id":"2518922104","title":"吉林敖东:公司核心业务涵盖中药、化药、生物制药及参业资源开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2518922104","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518922104?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:51","pubTimestamp":1741611066,"startTime":"0","endTime":"0","summary":"有投资者向吉林敖东提问, 董秘好!证监会发布“积极支持符合条件的吉林省企业通过首发和再融资募集资金,利用资本市场做大做强,充分发挥资本市场对吉林省经济发展的支持作用。”公司回答表示,尊敬的投资者:您好!公司核心业务涵盖中药、化药、生物制药及参业资源开发,与吉林省“医药强省”战略方向一致。具体情况请以公司在指定媒体披露的信息为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310205524abf2f094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310205524abf2f094&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0201","BK0188","BK0028","BK0074","000623","BK0086","561510","BK0239","562390","BK0012"],"gpt_icon":0},{"id":"2513289072","title":"吉林敖东:公司持有的广发证券采用权益法作为长期股权投资核算","url":"https://stock-news.laohu8.com/highlight/detail?id=2513289072","media":"证星董秘互动","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513289072?lang=zh_cn&edition=full","pubTime":"2025-02-22 11:00","pubTimestamp":1740193234,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东(000623)02月22日在投资者关系平台上答复投资者关心的问题。投资者:您好: 请问公司参股的广发证券,第一医药、南京医药,在资产负债表上,采取的是成本记帐还是市值记帐?谢谢吉林敖东董秘:尊敬的投资者:您好!根据《企业会计准则》核算要求,公司持有的广发证券采用权益法作为长期股权投资核算。公司持有的第一医药、南京医药作为交易性金融资产核算。感谢您对公司的关注和支持。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222110129988e7cfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222110129988e7cfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600713","BK0086","BK0188","BK0239","000623","BK0201","BK0012","BK0209","BK0074","600833","BK0028","BK0250","000776","BK0183","BK0276"],"gpt_icon":0},{"id":"2513247451","title":"吉林敖东:公司持有广发证券采用权益法核算,第一医药、南京医药为交易性金融资产核算","url":"https://stock-news.laohu8.com/highlight/detail?id=2513247451","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513247451?lang=zh_cn&edition=full","pubTime":"2025-02-22 09:52","pubTimestamp":1740189124,"startTime":"0","endTime":"0","summary":"金融界2月22日消息,有投资者在互动平台向吉林敖东提问:您好:请问公司参股的广发证券,第一医药、南京医药,在资产负债表上,采取的是成本记帐还是市值记帐?谢谢。公司回答表示:根据《企业会计准则》核算要求,公司持有的广发证券采用权益法作为长期股权投资核算。公司持有的第一医药、南京医药作为交易性金融资产核算。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222095440abd836e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222095440abd836e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0276","600833","BK0250","000623","BK0184","BK0086","BK0074","BK0201","BK0012","000776","BK0028","BK0097","BK0188","BK0209","BK0099","600713","BK0183","BK0239"],"gpt_icon":0},{"id":"2513226827","title":"吉林敖东:公司高度重视员工激励机制的建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2513226827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513226827?lang=zh_cn&edition=full","pubTime":"2025-02-21 18:30","pubTimestamp":1740133830,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东02月21日在投资者关系平台上答复投资者关心的问题。公司高度重视员工激励机制的建设,合理的激励措施能够有效提升员工的工作效率和创造力,目前公司员工持股计划尚在存续期内,公司严格按照相关法律法规及深交所有关规定履行信息披露义务。目前公司生产经营活动正常,各项业务有序推进,未发生重大不利变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022100034729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0188","000623","BK0086","BK0074","BK0028","BK0201"],"gpt_icon":0},{"id":"2511251627","title":"吉林敖东:公司在生产经营中积极与国内多家信息科技公司合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2511251627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511251627?lang=zh_cn&edition=full","pubTime":"2025-02-13 17:00","pubTimestamp":1739437223,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东02月13日在投资者关系平台上答复投资者关心的问题。公司在生产经营中积极与国内多家信息科技公司合作,在医药全流程管理引入信息化、数字化、智能化,逐步实现设备互联、数据互通、过程互动的智能制造模式,高质高效,推动实现公司高质量发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021300029301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0028","BK0086","BK0012","BK0074","000623","BK0188","BK0239"],"gpt_icon":0},{"id":"2510438657","title":"吉林敖东:公司目前经营的主业范围不涉及AI+相关业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2510438657","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510438657?lang=zh_cn&edition=full","pubTime":"2025-02-11 21:00","pubTimestamp":1739278815,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东02月11日在投资者关系平台上答复投资者关心的问题。AI+已经是国家战略了,请问敖东是否有这方面的构想和布局呢?公司目前经营的主业范围不涉及AI+相关业务。公司一直密切关注行业动态和技术变革,致力于通过科技创新推动医药产业升级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021100036714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0028","BK0012","BK0086","BK0239","BK0201","BK0188","000623"],"gpt_icon":0},{"id":"2510839826","title":"吉林敖东最新公告:控股子公司延边药业通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2510839826","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510839826?lang=zh_cn&edition=full","pubTime":"2025-02-10 17:20","pubTimestamp":1739179218,"startTime":"0","endTime":"0","summary":"吉林敖东公告称,公司控股子公司吉林敖东延边药业股份有限公司收到吉林省药品监督管理局核准签发的《药品GMP符合性检查告知书》。延边药业上述生产范围符合《药品生产质量管理规范》要求,公司将继续保持稳定的产品质量,生产安全、可靠、放心药,满足广大人民群众相关用药需求。但药品生产和销售受市场环境变化、行业政策等多种因素影响,存在一定不确定性,敬请广大投资者谨慎决策,注意防范投资风险。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021000022302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0188","BK0239","000623","BK0201","BK0012","BK0074","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746334638986,"stockEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":-0.0298},{"period":"3month","weight":-0.0397},{"period":"6month","weight":-0.0544},{"period":"1year","weight":0.1355},{"period":"ytd","weight":-0.0753}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.0087},{"period":"6month","weight":0.0021},{"period":"1year","weight":0.0561},{"period":"ytd","weight":-0.0217}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"吉林敖东药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"67022人(较上一季度减少0.60%)","perCapita":"17771股","listingDate":"1996-10-28","address":"吉林省延边朝鲜族自治州敦化市敖东大街2158号","registeredCapital":"119589万元","survey":" 吉林敖东药业集团股份有限公司的主营业务是中药、化学药品研发、制造和销售。公司的主要产品是中药、化学药品、连锁药店批发、零售。作为中华老字号及国家火炬计划重点高新技术企业,公司资产规模稳健增长,截至2024年末总资产达330.02亿元,净资产292.82亿元。凭借卓越的综合实力和行业影响力,公司连续十余年荣登中国制药工业百强榜单,2024中国中药研发实力排行榜TOP50中药榜第26位,并跻身“中国500最具价值品牌”,资产质量稳居行业前列。","listedPrice":7.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉林敖东(000623)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉林敖东(000623)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉林敖东,000623,吉林敖东股票,吉林敖东股票老虎,吉林敖东股票老虎国际,吉林敖东行情,吉林敖东股票行情,吉林敖东股价,吉林敖东股市,吉林敖东股票价格,吉林敖东股票交易,吉林敖东股票购买,吉林敖东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉林敖东(000623)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉林敖东(000623)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}